Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome

This publication has 33 references indexed in Scilit:

• Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
  Journal of Clinical Endocrinology & Metabolism, 1998
• Serum Androgen Levels in Women who Have Recurrent Miscarriages and their Correlation with Markers of Endometrial Function
  Fertility and Sterility, 1998
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
  Obstetrics & Gynecology, 1997
• Thrombophilia and fetal loss
  Blood Reviews, 1997
• Placental thrombosis and second trimester miscarriage in association with activated protein C resistance
  BJOG: An International Journal of Obstetrics and Gynaecology, 1996
• Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsia
  BJOG: An International Journal of Obstetrics and Gynaecology, 1994
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
  Metabolism, 1994
• Free testosterone and abortion in early pregnancy
  International Journal of Gynecology & Obstetrics, 1993
• Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.
  BMJ, 1988
• Metformin in management of pregnant insulin-independent diabetics
  Diabetologia, 1979